BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32358386)

  • 1. Clinical significance of the combined measurement of serum B7-H1 and interleukin-10 in colorectal cancer patients.
    Wang P; Li C; Ma X; Gai X
    Medicine (Baltimore); 2020 May; 99(18):e20044. PubMed ID: 32358386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
    Wang P; Li C; Zhang F; Ma X; Gai X
    Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinoma.
    Zhang SY; Lin M; Zhang HB
    Int J Clin Exp Pathol; 2015; 8(8):9404-9. PubMed ID: 26464695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of serum IL-23 in colorectal cancer.
    Elessawi DF; Alkady MM; Ibrahim IM
    Arab J Gastroenterol; 2019 Jun; 20(2):65-68. PubMed ID: 31155425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
    Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
    Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.
    Mroczko B; Szmitkowski M; Wereszczyńska-Siemiatkowska U; Okulczyk B
    Dig Dis Sci; 2005 Jun; 50(6):1019-24. PubMed ID: 15986847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum angiogenin as a potential biomarker for early detection of colorectal adenomas and colorectal cancer.
    Yu D; Sun J; Weng Y; Luo L; Sheng J; Xu Z
    Anticancer Drugs; 2021 Aug; 32(7):703-708. PubMed ID: 33661188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer.
    Wang D; Yuan W; Wang Y; Wu Q; Yang L; Li F; Chen X; Zhang Z; Yu W; Maimela NR; Cao L; Wang D; Wang J; Sun Z; Liu J; Zhang Y
    J Transl Med; 2019 Aug; 17(1):253. PubMed ID: 31387598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D; Yao Y; Yang C; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined analysis of survivin autoantibody and carcinoembryonic antigen biomarkers for improved detection of colorectal cancer.
    Chen JS; Chen KT; Fan WC; Yu JS; Chang YS; Chan EC
    Clin Chem Lab Med; 2010 May; 48(5):719-25. PubMed ID: 20178447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of serum IGFBP-3 in colorectal cancer.
    Hou YL; Luo P; Ji GY; Chen H
    J Clin Lab Anal; 2019 Jul; 33(6):e22912. PubMed ID: 31218761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Expression of
    Li S; Huang M; Liu Q; Wang D; Wu R; Zhang X; Chen W; Duan L
    Dis Markers; 2019; 2019():5070524. PubMed ID: 31781302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum sAPRIL: a potential tumor-associated biomarker to colorectal cancer.
    Ding W; Wang J; Wang F; Wang G; Wu Q; Ju S; Cong H; Wang H
    Clin Biochem; 2013 Oct; 46(15):1590-4. PubMed ID: 23792260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual association of serum interleukin-10 levels with colorectal cancer.
    Abtahi S; Davani F; Mojtahedi Z; Hosseini SV; Bananzadeh A; Ghaderi A
    J Cancer Res Ther; 2017; 13(2):252-256. PubMed ID: 28643743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
    Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
    Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression and significance of serum microRNA-135a-5p level in colorectal cancer].
    Wang QJ; Zhang HC; Shen XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):909-914. PubMed ID: 27998467
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of serum cytokine measurements in untreated colorectal cancer patients: soluble tumor necrosis factor receptor type I--an independent prognostic factor.
    Kaminska J; Nowacki MP; Kowalska M; Rysinska A; Chwalinski M; Fuksiewicz M; Michalski W; Chechlinska M
    Tumour Biol; 2005; 26(4):186-94. PubMed ID: 16006772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.